fadrozole has been researched along with Left Ventricular Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Favre, J; Henry, JP; Jeng, AY; Mellin, V; Monteil, C; Mulder, P; Remy-Jouet, I; Renet, S; Richard, V; Thuillez, C; Vercauteren, M; Webb, RL | 1 |
1 other study(ies) available for fadrozole and Left Ventricular Dysfunction
Article | Year |
---|---|
Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
Topics: Angiotensin Receptor Antagonists; Animals; Cytochrome P-450 CYP11B2; Endothelium, Vascular; Fadrozole; Heart Failure; Hemodynamics; Ligation; Male; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Rats; Rats, Wistar; Spironolactone; Ventricular Dysfunction, Left; Ventricular Remodeling | 2008 |